These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
645 related items for PubMed ID: 27325643
1. RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo-Yap Pathway. Guo PD, Lu XX, Gan WJ, Li XM, He XS, Zhang S, Ji QH, Zhou F, Cao Y, Wang JR, Li JM, Wu H. Cancer Res; 2016 Jul 01; 76(13):3813-25. PubMed ID: 27325643 [Abstract] [Full Text] [Related]
2. Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1. Si Y, Ji X, Cao X, Dai X, Xu L, Zhao H, Guo X, Yan H, Zhang H, Zhu C, Zhou Q, Tang M, Xia Z, Li L, Cong YS, Ye S, Liang T, Feng XH, Zhao B. Cancer Res; 2017 Sep 15; 77(18):4868-4880. PubMed ID: 28754671 [Abstract] [Full Text] [Related]
3. A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling. Zheng X, Chen L, Zhou Y, Wang Q, Zheng Z, Xu B, Wu C, Zhou Q, Hu W, Wu C, Jiang J. Mol Cancer; 2019 Mar 29; 18(1):47. PubMed ID: 30925892 [Abstract] [Full Text] [Related]
4. The ubiquitin E3 ligase ITCH enhances breast tumor progression by inhibiting the Hippo tumor suppressor pathway. Salah Z, Itzhaki E, Aqeilan RI. Oncotarget; 2014 Nov 15; 5(21):10886-900. PubMed ID: 25350971 [Abstract] [Full Text] [Related]
5. Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling. Sharif GM, Schmidt MO, Yi C, Hu Z, Haddad BR, Glasgow E, Riegel AT, Wellstein A. Oncogene; 2015 Nov 26; 34(48):5879-89. PubMed ID: 25772246 [Abstract] [Full Text] [Related]
6. Elucidation of WW domain ligand binding specificities in the Hippo pathway reveals STXBP4 as YAP inhibitor. Vargas RE, Duong VT, Han H, Ta AP, Chen Y, Zhao S, Yang B, Seo G, Chuc K, Oh S, El Ali A, Razorenova OV, Chen J, Luo R, Li X, Wang W. EMBO J; 2020 Jan 02; 39(1):e102406. PubMed ID: 31782549 [Abstract] [Full Text] [Related]
7. 2-Hydroxylation of Fatty Acids Represses Colorectal Tumorigenesis and Metastasis via the YAP Transcriptional Axis. Sun L, Yang X, Huang X, Yao Y, Wei X, Yang S, Zhou D, Zhang W, Long Z, Xu X, Zhu X, He S, Su X. Cancer Res; 2021 Jan 15; 81(2):289-302. PubMed ID: 33203703 [Abstract] [Full Text] [Related]
8. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis. Yang XM, Cao XY, He P, Li J, Feng MX, Zhang YL, Zhang XL, Wang YH, Yang Q, Zhu L, Nie HZ, Jiang SH, Tian GA, Zhang XX, Liu Q, Ji J, Zhu X, Xia Q, Zhang ZG. Gastroenterology; 2018 Oct 15; 155(4):1233-1249.e22. PubMed ID: 30009820 [Abstract] [Full Text] [Related]
9. Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner. Liu Y, Wang G, Yang Y, Mei Z, Liang Z, Cui A, Wu T, Liu CY, Cui L. Oncogene; 2016 May 15; 35(21):2789-800. PubMed ID: 26387538 [Abstract] [Full Text] [Related]
10. Regulation of the Hippo-YAP Pathway by Glucose Sensor O-GlcNAcylation. Peng C, Zhu Y, Zhang W, Liao Q, Chen Y, Zhao X, Guo Q, Shen P, Zhen B, Qian X, Yang D, Zhang JS, Xiao D, Qin W, Pei H. Mol Cell; 2017 Nov 02; 68(3):591-604.e5. PubMed ID: 29100056 [Abstract] [Full Text] [Related]
11. Expression of hippo pathway in colorectal cancer. Liang K, Zhou G, Zhang Q, Li J, Zhang C. Saudi J Gastroenterol; 2014 Nov 02; 20(3):188-94. PubMed ID: 24976283 [Abstract] [Full Text] [Related]
12. Regulation of YAP by mechanical strain through Jnk and Hippo signaling. Codelia VA, Sun G, Irvine KD. Curr Biol; 2014 Sep 08; 24(17):2012-7. PubMed ID: 25127217 [Abstract] [Full Text] [Related]
13. CRABP2 regulates invasion and metastasis of breast cancer through hippo pathway dependent on ER status. Feng X, Zhang M, Wang B, Zhou C, Mu Y, Li J, Liu X, Wang Y, Song Z, Liu P. J Exp Clin Cancer Res; 2019 Aug 16; 38(1):361. PubMed ID: 31419991 [Abstract] [Full Text] [Related]
14. RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3. Jang JW, Kim MK, Lee YS, Lee JW, Kim DM, Song SH, Lee JY, Choi BY, Min B, Chi XZ, Bae SC. Oncogene; 2017 Feb 16; 36(7):999-1011. PubMed ID: 27425596 [Abstract] [Full Text] [Related]
15. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway. Chen M, Wang M, Xu S, Guo X, Jiang J. Oncotarget; 2015 Dec 29; 6(42):44466-79. PubMed ID: 26561204 [Abstract] [Full Text] [Related]
16. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway. Fujimoto D, Ueda Y, Hirono Y, Goi T, Yamaguchi A. Oncotarget; 2015 Oct 27; 6(33):34788-99. PubMed ID: 26431277 [Abstract] [Full Text] [Related]
17. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis. Xu W, Yang Z, Xie C, Zhu Y, Shu X, Zhang Z, Li N, Chai N, Zhang S, Wu K, Nie Y, Lu N. J Exp Clin Cancer Res; 2018 Aug 22; 37(1):198. PubMed ID: 30134988 [Abstract] [Full Text] [Related]
18. Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway. Toloczko A, Guo F, Yuen HF, Wen Q, Wood SA, Ong YS, Chan PY, Shaik AA, Gunaratne J, Dunne MJ, Hong W, Chan SW. Cancer Res; 2017 Sep 15; 77(18):4921-4933. PubMed ID: 28720576 [Abstract] [Full Text] [Related]
19. An unconventional KITENIN/ErbB4-mediated downstream signal of EGF upregulates c-Jun and the invasiveness of colorectal cancer cells. Bae JA, Yoon S, Park SY, Lee JH, Hwang JE, Kim H, Seo YW, Cha YJ, Hong SP, Kim H, Chung IJ, Kim KK. Clin Cancer Res; 2014 Aug 01; 20(15):4115-28. PubMed ID: 24893630 [Abstract] [Full Text] [Related]
20. Activated Hippo/Yes-Associated Protein Pathway Promotes Cell Proliferation and Anti-apoptosis in Endometrial Stromal Cells of Endometriosis. Song Y, Fu J, Zhou M, Xiao L, Feng X, Chen H, Huang W. J Clin Endocrinol Metab; 2016 Apr 01; 101(4):1552-61. PubMed ID: 26977530 [Abstract] [Full Text] [Related] Page: [Next] [New Search]